Additive and synergistic bactericidal activity contributed by desacetylcefotaxime during cefotaxime therapy.
Moore
E S
ES
Clinical Division, College of Pharmacy, University of Texas, Austin.
Jimenez
M
M
Barriere
S L
SL
Cimino
M L
ML
Fekety
F R
FR
D002439:Cefotaxime / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D004357:Drug Synergism; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004755:Enterobacteriaceae / Q000187:drug effects; D006801:Humans; D008826:Microbial Sensitivity Tests
C029281:desacetylcefotaxime; D002439:Cefotaxime